Camlin Fine Sciences Limited — Important, 31-01-2025: Updates

The Securities Issue and Allotment Committee of Camlin Fine Sciences Limited has approved the allotment of 2,04,25,805 fully paid-up equity shares at an issue price of ₹ 110 per share through a rights issue. This successful allotment will increase the paid-up equity share capital from ₹ 16.75 crore to ₹ 18.79 crore. A small number of shares, 439, are pending regulatory clearances. This capital raise enhances the company's financial base, potentially supporting growth initiatives and strengthening its market positioning. Investors should monitor these developments closely, as the increased capital could provide opportunities for strategic advancements.